A carregar...

The efficacy and tolerability of mirabegron, a β3 adrenoceptor agonist, in patients with symptoms of overactive bladder

Mirabegron, is the only β-3 adrenoreceptor (AR) agonist available for the treatment of overactive bladder (OAB). To assess the efficacy and tolerability of this novel drug therapy, two phase II and six phase III Astellas-sponsored trials have been conducted with over 10,500 adults with OAB recruited...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Urol
Main Authors: Thiagamoorthy, Ganesh, Kotes, Stephanie, Zacchè, Martino, Cardozo, Linda
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707426/
https://ncbi.nlm.nih.gov/pubmed/26834839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215614237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!